Legal Experts Weigh In On The Amgen/Regeneron Patent Case
January 09, 2017 at 10:12 AM EST
Following the Federal Court decision to grant the injunction request from Amgen, Inc. (NASDAQ: AMGN) against the sale of Praluent, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.